On April 14, the PeptidesFromChina platform was officially launched, marking an important milestone in our mission to create a transparent and efficient sourcing environment for research peptides.
In the days following the launch, the platform has successfully processed its first requests from independent researchers. This early activity confirms both the demand for direct manufacturer access and the relevance of our model.
PeptidesFromChina was built to address key issues in the current market — lack of transparency, inconsistent quality, and reliance on intermediaries. Our approach focuses on connecting researchers directly with vetted manufacturers, ensuring clearer communication, better pricing structures, and improved control over sourcing.
While this is only the beginning, the initial traction and feedback have been highly encouraging. We are continuing to refine the platform, improve the user experience, and expand our network of trusted suppliers.
We would like to thank everyone who submitted early requests and contributed valuable feedback during this initial phase.
More updates coming soon.